Skip to content
OpenCapital
Get started

NeoGenomics NEO Market capitalization

Market capitalization at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$21.99B+12.9%
Quest Diagnostics logo
Quest DiagnosticsDGX
$21.53B+14.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$666.5M+115%
Guardant Health logo
Guardant HealthGH
$12.12B+130%
Natera, Inc. logo
Natera, Inc.NTRA
$28.34B+48.3%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$8.08B-2.7%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%—

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Computed from the period-end share price: $963.21M.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's market capitalization?
NeoGenomics (NEO) reported market capitalization of $963.21M in Q1 2026.
How has NeoGenomics's market capitalization changed year-over-year?
NeoGenomics's market capitalization decreased by 21.0% year-over-year, from $1.22B to $963.21M.
What is the long-term trend for NeoGenomics's market capitalization?
Over 5 years (2020 to 2025), NeoGenomics's market capitalization has grown at a -24.6% compound annual growth rate (CAGR), from $6.26B to $1.52B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.